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Abstract
Establishing the age of each mutation segregating in contemporary human populations is
important to fully understand our evolutionary history1,2 and will help facilitate the development
of new approaches for disease gene discovery3. Large-scale surveys of human genetic variation
have reported signatures of recent explosive population growth4-6, notable for an excess of rare
genetic variants, qualitatively suggesting that many mutations arose recently. To more
quantitatively assess the distribution of mutation ages, we resequenced 15,336 genes in 6,515
individuals of European (n=4,298) and African (n=2,217) American ancestry and inferred the age
of 1,146,401 autosomal single nucleotide variants (SNVs). We estimate that ~73% of all protein-
coding SNVs and ~86% of SNVs predicted to be deleterious arose in the past 5,000-10,000 years.
The average age of deleterious SNVs varied significantly across molecular pathways, and disease
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genes contained a significantly higher proportion of recently arisen deleterious SNVs compared to
other genes. Furthermore, European Americans had an excess of deleterious variants in essential
and Mendelian disease genes compared to African Americans, consistent with weaker purifying
selection due to the out-of-Africa dispersal. Our results better delimit the historical details of
human protein-coding variation, illustrate the profound effect recent human history has had on the
burden of deleterious SNVs segregating in contemporary populations, and provides important
practical information that can be used to prioritize variants in disease gene discovery.
As part of the NHLBI sponsored Exome Sequencing Project (ESP), we sequenced the
exomes of 6,515 individuals (Supplementary Table 1) including 4,298 European-Americans
(EAs) and 2,217 African-Americans (AAs). Exome data were subjected to standard quality
control filters as previously described6 (Supplementary Information), resulting in a data set
of 1,146,401 autosomal protein-coding SNVs with a known ancestral state (709,816 and
643,128 in EAs and AAs, respectively) distributed across 15,336 protein-coding genes. To
quantitatively estimate the age of each SNV (i.e., allele age), we developed a simulation
approach to generate a series of coalescent trees for a specified demographic model, and
estimated allele age based upon the derivation of Griffiths and Tavaré7 (Supplementary
Information). We verified the accuracy and robustness of this approach to factors including
recombination rate heterogeneity, population growth, migration, and purifying selection.
Extensive coalescent simulations demonstrated that we could accurately estimate the
expected allele age in the simulated data, although the variance associated with any
individual SNV can be large (Supplementary Fig. 6 and 7).
We estimated the age of all 1,146,401 SNVs using six different previously inferred
demographic models5,6,8-11, three of which considered recent explosive population
growth5,6,8 (Supplementary Table 2). Estimates of allele age were generally robust across
different demographic models, with the largest discrepancies resulting in a two-fold
difference in average age across all SNVs (Supplementary Table 3 and Supplementary Fig.
8a). However, because most SNVs arose recently (see below), differences among
demographic models were highly concordant (Supplementary Information). Accordingly,
we report results based on a modified Out-of-African model9 in which accelerated
population growth began 5,115 years ago with a per generation growth rate of 1.95% and
1.66% for EAs and AAs, respectively6.
The site frequency spectrum (SFS) of protein-coding SNVs revealed an enormous excess of
rare variants (Fig. 1a). Indeed, we observed a SNV approximately once every 52 bp and 57
bp in EAs and AAs, respectively, whereas in a population without recent explosive growth
we would expect the SNVs to occur once every 257 bp and 152 bp in EAs and AAs,
respectively (Supplementary Information). Thus, the EA and AA samples contain a ~5 and
~3-fold increase in SNVs, respectively, attributable to explosive population growth,
resulting in a large burden of rare SNVs predicted to have arisen very recently (Fig. 1b). For
example, the expected age of derived singletons, which comprise 55.1% of all SNVs, is
1,244 and 2,107 years for the EA and AA samples, respectively. Overall, 73.2% of SNVs
(81.4% and 58.7% in EAs and AAs, respectively) are predicted to have arisen in the past
5,000 years. SNVs that arose >50 thousand years (kyr) ago were observed more frequently
in the AA samples (Fig. 1b), which likely reflects stronger genetic drift in EAs associated
with the out of Africa dispersal.
The average age across all SNVs was 34.2±0.9 (s.d.) kyr in EAs and 47.6±1.5 kyr in AAs,
and these estimates were robust to sequencing errors (Supplementary Information;
Supplementary Fig. 9). As expected, SNVs shared between EAs and AAs were significantly
older (104.4 kyr and 115.8 kyr for EAs and AAs, respectively) than population-specific
variants (5.4 kyr and 15.3 kyr in EAs and AAs, respectively; Fig. 1c) (t-test; p<10-5 by
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permutation). Furthermore, there were large and significant differences among the average
allele age of SNVs stratified by functional type (t-test; p<10-5 by permutation). For instance,
splice site, nonsense, and non-synonymous SNVs were two to eight times younger
compared to synonymous and noncoding variants (Fig. 1d). Moreover, we classified amino
acids into four groups (non-polar and neutral, polar and neutral, acidic and polar, and basic
and polar), and nonsynonymous SNVs resulting in changes between groups were
significantly younger than those within groups (t-test; p<10-5 by permutation;
Supplementary Fig. 10a). These differences in average allele age are likely due to varying
intensities of selective constraint among different classes of SNVs12. Consistent with this
prediction, we observed significantly higher values of the neutrality index, a measure of the
direction and degree of departure from neutral evolution, in genomic regions enriched for
younger variants (Spearman's correlation; p=0.004 and 0.001 for EAs and AAs,
respectively; Supplementary Fig. 11), indicating a higher burden of deleterious SNVs.
To more directly identify putatively deleterious SNVs, we used four functional prediction
methods (SIFT13, PolyPhen214, a likelihood ratio test15, MutationTaster16) applicable to
nonsynonymous SNVs and two conservation-based methods (GERP++17 and PhyloP18)
applicable to all SNVs (Supplementary Information). We found a strong inverse relationship
between average SNV age and the number of methods that predicted a variant to be
deleterious (Fig. 2a and 2b). Thus, SNVs predicted to be deleterious by multiple methods
likely experience (on average) more intense purifying selection and may be of particular
interest in disease mapping studies, or to weight differently in rare variant association tests.
The age of nonsynonymous SNVs predicted to be deleterious by all six methods was 3.0 and
6.2 kyr in EAs and AAs, respectively, and 88.7% were <5 kyr (92.9% and 80.6% in EAs and
AAs, respectively).
The strengths and weaknesses of functional prediction methods vary substantially and as a
result the accuracy of any single method is modest15. Accordingly, we used a majority rule
approach to identify a more conservative set of SNVs predicted to be deleterious6.
Specifically, nonsynonymous SNVs predicted to be functionally significant by at least four
methods and all other SNVs (synonymous, splice, and noncoding variants) predicted by two
conservation-based methods were designated as deleterious. In total, 14.4% (164,688) of
SNVs, including 152,633 nonsynonymous variants, met these criteria. We found that allele
age was strongly related to the probability that a variant was predicted to be deleterious
(Supplementary Fig. 12), with the fraction of SNVs predicted to be deleterious diminishing
as allele age increased (Fig. 2c and Supplementary Fig. 13). The average age of
conservatively defined deleterious variants was 5.2±0.3 kyr for EAs and 10.1±0.6 kyr for
AAs. Moreover, 86.4% of these SNVs were predicted to have arisen in the past 5 kyr
(91.2% and 77.0% for EAs and AAs, respectively), corresponding to the onset of accelerated
population growth (Fig. 3a). In other demographic models, a similarly high proportion of
deleterious SNVs were predicted to have arisen since the onset of accelerated growth rates,
with the exact timing varying somewhat among models, but always in the timeframe of 5-10
kyr (Supplementary Table 3; Supplementary Fig. 8b and 8c).
Moreover, 7,197 (57.4%) of the 12,533 genes in EAs and 4,534 (37.5%) of the 11,607 genes
in AAs that harbor one or more deleterious variants only possess deleterious SNVs with an
estimated age of < 5 kyr (Fig. 3b). Thus, recent accelerated population growth has had a
large influence on the number of genes harboring deleterious variants in contemporary
populations. Notably, after correcting for exon length of each gene, three and eighteen genes
in EAs and in AAs, respectively, have a significant excess of deleterious variants that arose
after the onset of recent accelerated growth (p≤3×10-6; Supplementary Table 4), including
12 genes that have been associated with human diseases19 such as LAMC1 (premature
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ovarian failure20), LRP1 (Alzheimer Disease21), CPE (coronary artery atherosclerosis22),
and KIAA0196 (hereditary spastic paraplegia23).
Next, we investigated the distribution of ages for conservatively defined deleterious SNVs in
849 genes that cause Mendelian disorders24, 2,663 genes associated with complex
diseases19, 1,226 genes considered “essential” (i.e., a mouse knockout associated with
lethality or sterility)25, and 11,711 genes classified as “other” (Supplementary Information).
The proportion of deleterious SNVs in genes for Mendelian disorders (15.9%), essential
genes (15.2%), and genes associated with complex diseases (15.1%) were each significantly
higher (Fisher's exact test, p<10-16) compared to other genes (14.0%). In the EA samples,
the proportion of deleterious SNVs did not decline monotonically as a function of age for
Mendelian and essential genes. Rather, the proportion of deleterious variants with an
estimated age of 50-100 kyr in Mendelian disease genes and 100-150 kyr in essential genes
were elevated (Fig. 4a). This pattern was not observed in the AAs (Fig. 4a). To explore this
observation, we performed simulations to estimate the probability that a deleterious SNV
survives to the present day as a function of when the variant arose, the magnitude of
selection, and presence or absence of an out of Africa bottleneck (Supplementary
Information). Simulations of deleterious alleles in the presence of a bottleneck recapitulated
the patterns observed in EAs (Supplementary Fig. 14). Specifically, in the presence of a
bottleneck, weakly deleterious alleles (selection coefficient, s≤0.001) have an increased
probability of survival precisely in the intervals 50-100 kyr and 100-150 kyr. Thus, our
simulations suggest that genes underlying disease and essential genes are more functionally
constrained relative to other genes, and the bottleneck associated with the out of Africa
dispersal led to less efficient purging of weakly deleterious alleles26.
Finally, we found that the average age of deleterious variants (and the proportion of
deleterious variants; Supplementary Fig. 15) was significantly different across 235 KEGG
pathways (Kruskal-Wallis Rank Sum Test; p=2.5×10-3 and 1.08×10-6 for EAs and AAs,
respectively; Fig. 4b; Supplementary Information). The average age across pathways did not
vary significantly when all SNVs were considered (Kruskal-Wallis Rank Sum Test; p=0.259
and 0.075 for EAs and AAs, respectively), indicating the differences observed for
deleterious variants likely represent heterogeneity of functional constraint across pathways.
In general, the average age of deleterious variants in metabolic pathways was older than that
in other pathways (Mann-Whitney test, p=1.11×10-4 and 6.27×10-9 for EAs and AAs,
respectively), suggesting they are subject to less functional constraint. Conversely,
deleterious variants in human disease pathways (Mann-Whitney test, p=0.03 for AAs) and in
pathways involved in organismal systems were significantly younger (Mann-Whitney test,
p=0.04 and 0.002 for EAs and AAs, respectively).
In summary, the spectrum of protein-coding variation is considerably different today
compared to what existed even as recently as 200 – 400 generations ago. 86.4% of
putatively deleterious protein-coding SNVs arose in the last 5-10 kyr, which are enriched for
mutations of large effect (Supplementary Fig. 14), as selection has not had sufficient time to
purge them from the population. It thus seems likely that rare variants play a significant role
inheritable phenotypic variation, disease susceptibility, and adverse drug responses. In
principle, our results provide a framework for developing new methods to prioritize
potential disease causing variants in gene mapping studies. More generally, the recent
dramatic increase in human population size, resulting in a deluge of rare functionally
important variation, has important implications for understanding and predicting current and
future patterns of human disease and evolution. For instance, the increased mutational
capacity of recent human populations has led to a larger burden of Mendelian disorders,
increased the allelic and genetic heterogeneity of traits, and may have created a new
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repository of recently arisen advantageous alleles that adaptive evolution will act upon in
subsequent generations27.
Methods Summary
Exome sequences were obtained for 6,823 individuals, who were sequenced to high-
coverage (median depth > 100x) on an Illumina GAII or HiSeq2000. Library construction,
exome capture, sequencing, mapping, calling and filtering were performed as previously
described, with minor modifications6 (and see Supplementary Information). After quality
control and removal of related individuals, 6,515 individuals were retained. Ancestry of each
individual was inferred by PCA performed on the sequence data. We developed a simulation
approach based on coalescent theory to estimate allele age, which was applied to 1,146,401
autosomal SNVs with known ancestral states. A complete description of the materials and
methods is provided in Supplementary Information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The vast majority of protein-coding SNVs arose recently
a, The site frequency spectrum for EAs (red) and AAs (blue). b, Cumulative proportion of
SNVs for a given allele age. The inset highlights the cumulative proportion of SNVs that are
estimated to have arisen in the last 50 kyr. c, Average age for all SNVs, SNVs found in both
the EAs and AAs (shared), and SNVs found in only one population (specific). d, Average
age for different types of variants. Error bars denote standard deviations.
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Figure 2. Characteristics of allele age for deleterious SNVs
a and b, average age of nonsynonymous and other SNVs as a function of the number of
methods that predict the variant to be deleterious. Pie charts represent the proportion of
SNVs that arose less than (black) or more than (white) 5 kyr. Error bars denote standard
deviations. c, Relationship between the proportion of SNVs predicted to be deleterious and
SNV age. Note, >99% of deleterious SNVs are estimated to have arisen in the past 150 Kyr.
Solid lines represent a loess fit to the data.
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Figure 3. Distribution of deleterious SNVs across the exome before and after recent accelerated
population growth
a, Rectangles represent the set of all protein-coding sequences for each chromosome.
Vertical red and blue lines in EAs and AAs, respectively, denote deleterious SNVs. The
distributions of deleterious SNVs across the exome before and after recent accelerated
population growth are shown in the left and right panels, respectively. b, The bar plots
summarize the number of genes segregating one or more deleterious SNVs that arose before
(left) or after (right) recent accelerated population growth.
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Figure 4. Heterogeneity of allele age across genes and pathways
a, Distribution of the proportion of deleterious SNVs for Mendelian, complex, essential, and
other genes in EAs (top) and AAs (bottom) versus age in kyr. Data for each of the four
categories of genes is shown in each plot, with darker lines representing the specific gene
class indicated by the column label. Shaded regions define 95% confidence intervals
obtained by bootstrapping. b, Average ages for deleterious (projecting up) and all
(projecting down) SNVs across 235 KEGG pathways that can be organized into six broad
classes (see legend on the right). Each of the six classes is comprised of multiple sub-
classes, indicated by the different color shadings.
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